Monday, November 11, 2024
wellness India Expo
Home Tags SARS-CoV-2

Tag: SARS-CoV-2

Indian Immunologicals develops first-of-its kind needle-free COVID-19 intranasal vaccine

IIL in partnership with Griffith University, Australia developed needle free intra-nasal booster vaccine against SARS-CoV-2 using codon deoptimization technology

Could auto-antibodies be linked to severe COVID-19?

Researchers reveal auto-antibodies to type I IFNs block IFN signaling, contributing to severe COVID-19 by impairing the immune response

Fresh insights into spread of airborne pathogens in indoor spaces

Researchers at the Indian Institute of Technology Delhi, in a study, have demonstrated the role of aerosol dispersion of SARS-Cov-2 virus and similar airborne pathogens in the spread of the disease in enclosed spaces

New method of visual detection of SARS-CoV-2 can identify the infection...

Popularly used gold standard techniques such as RT-PCR and ELISA are usually time-consuming, require skilled labor, specific equipment and are not feasible for on-site detection

Genetic recombination made Omicron more infectious

The Indian researchers have found that recombination events had escalated during the Omicron wave, which made the virus more immune-evasive and infectious.

Researchers devise field deployable alternative to RT-PCR

The newly developed ‘Recombinase Polymerase Amplification (RPA)’ method, wherein all the reactions take place close to room temperature, does not require a thermal cycler

Researchers develop VLP-based vaccine candidate for Covid-19

A safer and easier strategy is to use virus-like particles (VLPs), the molecular mimics that look and act like a particular virus without being infectious

Exclusive: Antibody against multiple emerging SARS-CoV-2 variants

A broadly neutralizing highly potent human monoclonal antibody developed in India against multiple emerging SARS-CoV-2 variants

Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene partnership with Bharat Biotech &...

An entirely new “chimeric” spike antigen complex, different from any protein of existing SARS-CoV-2 variants, will be generated

How did COVID-19 spread during short conversations?

The simulations from a recent research showed that the risk of getting infected was higher when one person acted as a passive listener than when they engaged in a two-way conversation